Optimizing risk factors influence Intensive Care stay after Hyperthermic Intraperitoneal Chemotherapy? An observational cohort study

Optimizing risk factors influence Intensive Care stay after Hyperthermic Intraperitoneal Chemotherapy? An observational cohort study

<h3>Background</h3><p dir="ltr">It may be necessary to admit patients receiving Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to the intensive care unit (ICU). They were required to evaluate the length of ICU stay (LOS) following HIPEC, as well as their survival rates...

Full description

Saved in:
Bibliographic Details
Main Author: Hamed Elgendy (11570543) (author)
Other Authors: Masood Iqbal (17346892) (author), Talha Youssef (14148849) (author), Abdulaziz Alzahrani (4556308) (author), Asia Rugaan (17346895) (author)
Published: 2022
Subjects:
Biomedical and clinical sciences
Clinical sciences
Oncology and carcinogenesis
Optimization
Risk factors
Length of stay
Hyperthermic intraperitoneal chemotherapy
Outcome
Intensive care unit
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items